With the help of the data and tweets given, can you forecast whether the closing price of $jnj will climb or drop at 2017-03-01? Please state either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-02-14,-0.8,0.0,-0.9,0.4,0.4,-1.2,-1.8,-2.2,-2.2,-2.0,-1.7
2017-02-15,-1.1,0.2,-1.4,0.7,0.7,-1.2,-2.2,-2.7,-2.8,-2.7,-2.4
2017-02-16,-0.9,0.2,-0.9,0.8,0.8,-1.3,-2.5,-3.0,-3.4,-3.3,-3.0
2017-02-17,-0.6,0.0,-0.7,0.7,0.7,-1.3,-2.7,-3.4,-3.8,-3.8,-3.6
2017-02-21,-1.1,0.2,-1.1,0.7,0.7,-1.4,-2.9,-3.7,-4.2,-4.3,-4.2
2017-02-22,-0.2,0.2,-0.2,-0.1,-0.1,-0.7,-2.3,-3.2,-3.8,-4.0,-4.0
2017-02-23,-1.8,0.2,-1.8,1.8,1.8,-1.8,-3.3,-4.5,-5.1,-5.5,-5.5
2017-02-24,-1.0,0.0,-1.5,0.8,1.5,-2.3,-4.0,-5.3,-6.1,-6.6,-6.7
2017-02-27,-0.2,0.4,-0.2,-0.3,-0.3,-1.4,-3.1,-4.6,-5.4,-6.0,-6.2
2017-02-28,-0.2,0.4,-0.2,-0.2,-0.2,-0.7,-2.4,-3.9,-4.9,-5.6,-5.8

2017-02-14: paulson goes 13g grabbing more valeant shares in q4 $vrx $agn $myl $mrk $jnj $brk $aapl $ko $pep $exel $cake $tst¡­ |mega cap stock and option trading model subscriptions available at profectus system
2017-02-15: rt AT_USER valeant's brodalumab approval proves another example of wells fargo short &amp; distort! $vrx $agn $myl $mrk $aapl $hlf $iep $b¡­|short &amp; distort or just complete incompetence again! fi
2017-02-16: valeant botches delayed brodaluma approval pr excluding amended license consideration $vrx $agn $myl $mrk $azn $bmy¡­ |hurry up and grab some #johnsonjohnson before the stock bursts even more. read mo
2017-02-17: $jnj right through daily 200sma with ease, into an area of potential resistance, any pullback into the support area¡­ |johnson &amp; johnson $jnj vp paulus stoffels sells 22,000 shares |johnson &amp; 
2017-02-18: $spx spdr health care sector etf components. $bmy $gld $unh $abbv $biib $jnj $mdt $xlv $lly $pfe $celg $mrk $tmo¡­ |rt AT_USER more bullish, schwab investors are on the prowl for stocks $schw  $aapl $
2017-02-19: 02/17/17 volume leader #98 - jnj 8,691,101 johnson &amp; johnson $jnj 118.86 +0.78 +0.66% high today of 118.90 day |the most successful dividend investors ever $pep also $brk.a $abt $jnj $ko $mkc $pg 
2017-02-20: $jnj johnson &amp; johnson stock analysis -  via AT_USER #dividend #king #healthcare¡­ |rt AT_USER it does not make any sense. 3% in $jnj is a big move, 3% in $drys is a blip on the chart. as the worl
2017-02-21: AT_USER AT_USER $jnj  stock deal, also don't think it's likely but actelion all oversees cash&amp;minimal integration, so doesn't preclude|AT_USER they will get pfizered $pfe, maybe $nvs makes sense w
2017-02-22: rt AT_USER $jnj is the world's most admired drug company according to forbes, but who else made the 2017 list? |$jnj is the world's most admired drug company according to forbes, but who else made the
2017-02-23: rt AT_USER $jnj "knew...about risks and chose to conceal these dangers from the public to protect profits instead of people." #hern¡­|7 blue-chip stocks that are flush with cash $aapl $ge $jnj $ko $ms
2017-02-24: rt AT_USER shuts out the paid for silence media. shuttles in the rat #serialkillerceo $jnj alex gorsky promotion for profit. patient¡­|rt AT_USER women injured by $jnj's tvt &amp; gynecare mesh that v
2017-02-25: commented on johnson &amp; johnson to acquire actelion for $30 billion: is this a smart move?  $jnj $aliof $alioy|commented on actelion: good things come to those that get companies for free  $aliof $
2017-02-27: johnson &amp; johnson discloses doj inquiry on olysio, states massachusetts is probing non-profit aid:¡­ |rt AT_USER single-digit price-hike pledge? j&amp;j has that covered already, company report sa
Answer:
With the help of the data and tweets given, can you forecast whether the closing price of $jnj will climb or drop at 2017-03-01? Please state either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-02-14,-0.8,0.0,-0.9,0.4,0.4,-1.2,-1.8,-2.2,-2.2,-2.0,-1.7
2017-02-15,-1.1,0.2,-1.4,0.7,0.7,-1.2,-2.2,-2.7,-2.8,-2.7,-2.4
2017-02-16,-0.9,0.2,-0.9,0.8,0.8,-1.3,-2.5,-3.0,-3.4,-3.3,-3.0
2017-02-17,-0.6,0.0,-0.7,0.7,0.7,-1.3,-2.7,-3.4,-3.8,-3.8,-3.6
2017-02-21,-1.1,0.2,-1.1,0.7,0.7,-1.4,-2.9,-3.7,-4.2,-4.3,-4.2
2017-02-22,-0.2,0.2,-0.2,-0.1,-0.1,-0.7,-2.3,-3.2,-3.8,-4.0,-4.0
2017-02-23,-1.8,0.2,-1.8,1.8,1.8,-1.8,-3.3,-4.5,-5.1,-5.5,-5.5
2017-02-24,-1.0,0.0,-1.5,0.8,1.5,-2.3,-4.0,-5.3,-6.1,-6.6,-6.7
2017-02-27,-0.2,0.4,-0.2,-0.3,-0.3,-1.4,-3.1,-4.6,-5.4,-6.0,-6.2
2017-02-28,-0.2,0.4,-0.2,-0.2,-0.2,-0.7,-2.4,-3.9,-4.9,-5.6,-5.8

2017-02-14: paulson goes 13g grabbing more valeant shares in q4 $vrx $agn $myl $mrk $jnj $brk $aapl $ko $pep $exel $cake $tst¡­ |mega cap stock and option trading model subscriptions available at profectus system
2017-02-15: rt AT_USER valeant's brodalumab approval proves another example of wells fargo short &amp; distort! $vrx $agn $myl $mrk $aapl $hlf $iep $b¡­|short &amp; distort or just complete incompetence again! fi
2017-02-16: valeant botches delayed brodaluma approval pr excluding amended license consideration $vrx $agn $myl $mrk $azn $bmy¡­ |hurry up and grab some #johnsonjohnson before the stock bursts even more. read mo
2017-02-17: $jnj right through daily 200sma with ease, into an area of potential resistance, any pullback into the support area¡­ |johnson &amp; johnson $jnj vp paulus stoffels sells 22,000 shares |johnson &amp; 
2017-02-18: $spx spdr health care sector etf components. $bmy $gld $unh $abbv $biib $jnj $mdt $xlv $lly $pfe $celg $mrk $tmo¡­ |rt AT_USER more bullish, schwab investors are on the prowl for stocks $schw  $aapl $
2017-02-19: 02/17/17 volume leader #98 - jnj 8,691,101 johnson &amp; johnson $jnj 118.86 +0.78 +0.66% high today of 118.90 day |the most successful dividend investors ever $pep also $brk.a $abt $jnj $ko $mkc $pg 
2017-02-20: $jnj johnson &amp; johnson stock analysis -  via AT_USER #dividend #king #healthcare¡­ |rt AT_USER it does not make any sense. 3% in $jnj is a big move, 3% in $drys is a blip on the chart. as the worl
2017-02-21: AT_USER AT_USER $jnj  stock deal, also don't think it's likely but actelion all oversees cash&amp;minimal integration, so doesn't preclude|AT_USER they will get pfizered $pfe, maybe $nvs makes sense w
2017-02-22: rt AT_USER $jnj is the world's most admired drug company according to forbes, but who else made the 2017 list? |$jnj is the world's most admired drug company according to forbes, but who else made the
2017-02-23: rt AT_USER $jnj "knew...about risks and chose to conceal these dangers from the public to protect profits instead of people." #hern¡­|7 blue-chip stocks that are flush with cash $aapl $ge $jnj $ko $ms
2017-02-24: rt AT_USER shuts out the paid for silence media. shuttles in the rat #serialkillerceo $jnj alex gorsky promotion for profit. patient¡­|rt AT_USER women injured by $jnj's tvt &amp; gynecare mesh that v
2017-02-25: commented on johnson &amp; johnson to acquire actelion for $30 billion: is this a smart move?  $jnj $aliof $alioy|commented on actelion: good things come to those that get companies for free  $aliof $
2017-02-27: johnson &amp; johnson discloses doj inquiry on olysio, states massachusetts is probing non-profit aid:¡­ |rt AT_USER single-digit price-hike pledge? j&amp;j has that covered already, company report sa
Answer:+Rise